BDBM50291389 3-{(E)-3-Carbamoyl-2-methyl-1-[1-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-anthracen-2-yl)-meth-(E)-ylidene]-allyl}-benzamide::CHEMBL424386
SMILES: C\C(=C/C(N)=O)\C(=C\c1ccc2cc3c(cc2c1)C(C)(C)CCC3(C)C)\c1cccc(c1)C(N)=O
InChI Key: InChIKey=MWLTYZJQCIBUFG-KGOGZVLYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cPLA2 C2 (Homo sapiens (Human)) | BDBM50291389 (3-{(E)-3-Carbamoyl-2-methyl-1-[1-(5,5,8,8-tetramet...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article | n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Compound was measured for the inhibition of human platelet PLA2 (HP-PLA2) | Bioorg Med Chem Lett 7: 793-798 (1997) Article DOI: 10.1016/S0960-894X(97)00110-8 BindingDB Entry DOI: 10.7270/Q26D5T0F | |||||||||||
More data for this Ligand-Target Pair |